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Case Report

Stones, bones, groans, thrones, and psychiatric overtones:
Systemic associations of sclerochoroidal calcification
Jordan A. Sugarman, Alexzandra M. Douglass, Emil Anthony T. Say, Carol L. Shields
Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA 19107, USA

Sclerochoroidal calcification (SCC) is a frequent
masquerader of choroidal melanoma with important
systemic associations such as hyperparathyroidism and
parathyroid adenoma. Herein, we describe a case of a
67‑year‑old male who presented with an amelanotic
choroidal lesion in the right eye (OD) and a history
of kidney stones. Ultrasonography showed the lesion
to be flat and calcified OD. Incidentally, a subclinical
calcified plaque was also found in the fellow eye.

Introduction
Sclerochoroidal calcification (SCC) is characterized by calcium
deposition within the sclera giving rise to flat or protruding
yellow‑white amelanotic lesions in the fundus.[1,2] SCC can
masquerade as various intraocular tumors and is frequently
misdiagnosed as choroidal metastasis or choroidal osteoma. The
confusion with choroidal osteoma stems from the presence of
calcification within both tumors; however, the clinical features
differ in that osteoma affects young patients whereas SCC affects
the elderly.[3] Furthermore, choroidal osteoma is typically flat and
peripapillary in location with linear opacities within the choroid on
optical coherence tomography (OCT).[4] In contrast, SCC appears
more often in the superotemporal equator as a nodular elevation
with shadowing on OCT emanating from the sclera outward.[1]
Most cases of SCC require no treatment, since calcium deposition
is often stable and vision loss does not generally occur.[1] SCC
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Optical coherence tomography showed an elevated
suprachoroidal mass in a table mountain configuration
OD and flat configuration left eye, consistent with
type 4 and type 1 SCC. The patient was referred for
metabolic testing to rule out the underlying electrolyte
imbalance and was found to be normal.
Keywords: Eye, hyperparathyroidism, parathyroid
adenoma, sclera, sclerochoroidal calcification

is more often idiopathic, but in some cases, calcification could
be indicative of an underlying imbalance in calcium/phosphate
metabolism. Such imbalances have rarely been associated with renal
dysfunction due to Gitelman syndrome and Bartter syndrome, and
more frequently hyperparathyroidism.[1] Hyperparathyroidism
manifests clinically with renal stones, bone pain, abdominal pain,
polyuria, and psychiatric symptoms such as depression, anxiety,
insomnia, cognitive dysfunction, and even coma.[1] This collection
of symptoms has led to the popular mnemonic device of “stones,
bones, groans, thrones, and psychiatric overtones.”[1]
Herein, we report a recent case of a 67‑year‑old male with kidney
stones referred for multifocal yellow‑white tumors in the choroid
and found to have SCC.

Case Report
A 67‑year‑old white male was referred for a small amelanotic
choroidal tumor in his right eye (OD) found on routine
examination and suspected to be choroidal nevus or metastasis.
Medical history revealed primary open angle glaucoma, kidney
stones of unspecified composition, high cholesterol, and surgical
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removal of his gallbladder. On examination, visual acuity was
20/20 in both eyes. Intraocular pressure was 14 mmHg in the OD
and 13 mmHg in the left eye (OS), and both eyes showed mild
nuclear sclerosis on slit‑lamp examination.
Fundus examination of the OD revealed a poorly defined yellow
deep nodular lesion superotemporally, appearing to reside in the
choroid [Figure 1a]. This lesion was dense on ultrasonography with
acoustic shadowing consistent with calcification. Although the clinical
examination of the left fundus was unremarkable, ultrasonography
confirmed flat dense lesions superotemporally with calcification and
orbital shadowing. Both eyes were consistent with SCC.
OCT revealed scleral thickening and shadowing in both eyes,
associated with compression of the overlying choroid, more so the
OD than the OS. These lesions are consistent with SCC and are
distinguished from other choroidal tumors by its suprachoroidal
location, preserved overlying choroidal and retinal structures, and
thinning or the choroid at its margins.[5] Furthermore, they can
be classified as type 4 or “table mountain” formation in the OD
and type 1 or “flat” in the OS.[5] A clinical diagnosis of SCC was
made, and the patient was referred for testing of serum calcium,
phosphorus, magnesium, and potassium as well as parathyroid
hormone. This, along with the renal stones, suggested the
underlying calcium disequilibrium.

Discussion
The diagnosis of SCC is often overlooked. In one series of 118
consecutive patients, a correct referring diagnosis was made
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Figure 1: A 67‑year‑old male presented with an amelanotic lesion in the right eye
along the superotemporal quadrant (a). Fundus examination of the left eye was
unremarkable (b), but arrow points to the site of ultrasonographically detected deep
calcification. Ultrasonography of the right eye (c) depicted a flat hyperechoic lesion with
shadowing consistent with calcification, and this was similarly found superotemporally
in the left eye (d). Optical coherence tomography showed suprachoroidal hyporeflective
lesions consistent with sclerochoroidal calcification in a table mountain formation in the
right eye (e) and a flat formation in the left eye (f)
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in only 5% of the cases.[1] Further, there have been reported
cases of SCC erroneously treated with radiotherapy for fear of a
more serious diagnosis such as melanoma.[6] Hence, the correct
diagnosis of SCC is important to avoid unwarranted treatment
that could result in visual compromise.
The occurrence of SCC is often isolated without systemic
associations. The initial reports on SCC demonstrated that this
condition is rarely associated with primary hyperparathyroidism,
hypomagnesemia, Gitelman syndrome, and Bartter syndrome.[7‑10]
A more recent update, however, provided evidence that association
with electrolyte imbalance in the setting of hormonal abnormalities
could occur more often than expected. Our team reported
parathyroid adenoma in 15% of the patients with SCC and
hyperparathyroidism in 27% of those who underwent systemic
testing.[1] The parathyroid gland is composed primarily of chief
cells that synthesize and release parathyroid hormone to regulate
calcium and phosphate metabolism. Parathyroid adenoma is
caused by abnormal proliferation of chief cells leading to elevated
parathyroid hormone (primary hyperparathyroidism), while the
secondary hyperparathyroidism is more often caused by renal
dysfunction with elevated serum calcium requiring compensation
by the parathyroid gland. Our patient manifested with two features
of metabolic calcium dysfunction including renal stones and SCC,
both potentially related to systemic hypercalcemia, possible renal
dysfunction, and secondary hyperparathyroidism.
Primary renal tubular hypokalemic metabolic alkalosis syndromes
such as Bartter and Gitelman syndromes are more serious conditions
associated with SCC.[7‑10] These renal abnormalities constitute
a group of similar autosomal recessive disorders of sodium
chloride transport causing renal tubular hypokalemic metabolic
alkalosis.[11] Clinically, Bartter syndrome presents in childhood
with polyuria, polydipsia, vomiting, frequent dehydration, and
failure to thrive.[11] Gitelman syndrome is characterized by a
milder onset in late childhood or early adulthood, with clinical
symptoms including fatigue, muscle weakness, and carpopedal
spasm.[11] These symptoms are in addition to the classical
presentation of hypokalemia and metabolic alkalosis. Patients
with these syndromes are at a high risk for vascular incident
with the use of anesthesia.[11] Therefore, it is important to be
aware of these syndromes in addition to hyperparathyroidism in
the differential diagnosis when considering SCC. Both of these
renal abnormalities are treatable, and symptoms are reversible
with proper treatment. Bartter syndrome is primarily treated
with potassium supplementation and prostaglandin synthase
inhibitors, with the main goal of correcting hypokalemia.[11]
Gitelman syndrome is treated with oral magnesium pyrrolidone
carboxylate supplementation.[11] The mechanism of SCC in
relation to Bartter and Gitelman syndromes is not yet understood.
In summary, SCC is a benign calcified tumor seen in older adults
that is visually insignificant. Although treatment is not required,
blood tests are necessary to check for electrolyte imbalance and
hormonal abnormalities in relation to calcium, phosphorus,
magnesium, and potassium metabolism.
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